Fazhanleisheng Tablets (marketed as Bailemian), China’s first domestically developed innovative anti-insomnia drug, have officially made their online debut on the Meituan Medicine platform. As a dual orexin receptor antagonist (DORA), this medication effectively targets excessive wakefulness signals without disrupting the body’s natural sleep architecture, making it an ideal option for treating insomnia in adults. According to Meituan Medicine’s data, since the introduction of this new generation of DORA-based sleep aids, the platform has witnessed double-digit compound growth in related orders—a clear indication of the soaring demand among consumers for cutting-edge sleep therapy solutions.
